Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Digoxin therapy for heart failure: an update.

Spencer A Morris1, H Floyd Hatcher, Deepa K Reddy

  • 1Georgetown Hospital System, Georgetown, South Carolina 29440, USA. spenceamorris@aol.com

American Family Physician
|August 31, 2006
PubMed
Summary

Digoxin therapy for heart failure did not affect mortality but reduced hospitalizations and improved symptoms. Further research is needed to clarify optimal digoxin use, especially in women.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The less familiar side of heart failure: symptomatic diastolic dysfunction.

The Journal of family practiceยท2005
See all related articles

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Digoxin is a long-standing treatment for heart failure.
  • Its precise role and optimal use in heart failure management remain subjects of ongoing investigation.

Purpose of the Study:

  • To re-evaluate the effectiveness of digoxin in heart failure treatment based on new analyses of existing trial data.
  • To investigate the impact of serum digoxin concentration and patient demographics on treatment outcomes.

Main Methods:

  • Reanalysis of data from the Digitalis Investigation Group (DIG) trial.
  • Examination of subgroup analyses focusing on serum digoxin levels and patient characteristics, including sex.

Main Results:

  • Adding digoxin to standard therapy did not alter mortality rates in heart failure patients.
  • Digoxin significantly decreased heart failure-related hospitalizations and improved patient symptoms.
  • Lower serum digoxin concentrations showed the most benefit in patients with severe heart failure.
  • Retrospective analysis suggested an increased mortality risk associated with digoxin use in women, requiring cautious interpretation.

Conclusions:

  • Digoxin may be beneficial for reducing hospitalizations and improving symptoms in heart failure, particularly at lower serum concentrations in severe cases.
  • Further prospective trials are necessary to establish optimal digoxin dosing and clarify its role in women with heart failure.
  • Digoxin is not indicated for diastolic heart failure and is not a first-line treatment for atrial fibrillation in heart failure patients.

Related Experiment Videos